NV5 Global Form 4 Confirms Acuren Merger; CFO Converts Shares to 1.1523x Acuren + $10
Rhea-AI Filing Summary
Form 4 discloses that Edward H. Codispoti, Chief Financial Officer of NV5 Global, Inc. (NVEE), no longer holds NVEE common stock following the closing of the company’s merger with Acuren Corporation on 08/04/2025. The filing records a single disposition transaction coded “D” for 89,154 NVEE shares. Pursuant to the May 14 2025 Agreement and Plan of Merger, each NVEE share—including vested restricted-stock awards—was converted into the right to receive 1.1523 Acuren shares plus $10.00 in cash per share. After the conversion, Codispoti’s beneficial ownership in NVEE is 0.
No derivative security transactions were reported. The transaction was filed by one reporting person and was executed under ordinary merger terms; there is no indication of a Rule 10b5-1 trading plan. The filing confirms the equity-for-cash consideration structure and indicates that all insider NVEE equity has been exchanged, signaling the consummation of the merger.
Positive
- Merger consummation confirmed: Filing validates that the NV5–Acuren transaction closed on 08/04/2025 and consideration was delivered as promised.
- Immediate liquidity: Shareholders, including the CFO, receive $10.00 cash per share in addition to Acuren stock.
Negative
- Loss of NVEE insider alignment: CFO now holds zero NVEE shares, ending direct management equity stake in the legacy entity.
Insights
TL;DR: Insider’s NVEE stake converted to Acuren stock and cash; confirms merger close, neutral cash-outflow impact.
The disposition of 89,154 shares by the CFO is mechanical—triggered by the merger with Acuren. Because every NVEE shareholder receives identical consideration, the insider sale is not an idiosyncratic signal about valuation or future performance. The filing does, however, corroborate that the merger has closed and that share conversion mechanics have been executed, which may affect float and index membership. Overall impact is neutral for existing NVEE investors (who are now Acuren shareholders) but removes NV5 insider-ownership visibility.
TL;DR: Filing evidences completion of NV5–Acuren merger; payout terms exactly as stipulated.
The Form 4 shows automatic vesting of restricted shares and conversion into the agreed merger consideration—1.1523 Acuren shares + $10 cash per NVEE share. No price premium beyond the merger terms is indicated. From a deal-process perspective, this is a routine post-closing administrative step. The elimination of NVEE insider holdings supports the legal merger effective date and simplifies future corporate governance under Acuren. Investor impact is modest; key takeaway is confirmation of deal consummation.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Disposition | Common Stock | 89,154 | $0.00 | $0.00 |
Footnotes (1)
- F1. Pursuant to the Agreement and Plan of Merger, dated as of May 14, 2025 (the "Merger Agreement"), by and among NV5 Global, Inc. (the "Company"), Acuren Corporation ("Acuren"), Ryder Merger Sub I, Inc. and Ryder Merger Sub II, Inc., each outstanding share of common stock of the Issuer was converted into the right to receive 1.1523 shares of Acuren common stock per share and $10.00 in cash per share (together, the "Merger Consideration"). In addition, pursuant to the Merger Agreement, any outstanding restricted stock award of NV5 held by the Reporting Person automatically vested in full in accordance with its terms immediately prior to the effective time of the mergers and converted into the right to receive the Merger Consideration, less applicable tax withholdings.
FAQ
What did NV5 Global's CFO report on the Form 4 dated 08/06/2025?
Were any derivative securities involved in the transaction?
AI-generated analysis. How Rhea-AI works. Not financial advice.
